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Objective—To evaluate whether the presence of condition-specific obstetric protocols within a 
hospital was associated with better maternal and neonatal outcomes.
Study Design—Cohort study of a random sample of deliveries performed at 25 hospitals over 
three years. Condition-specific protocols were collected from all hospitals and categorized 
independently by two authors. Data on maternal and neonatal outcomes, as well as data necessary 
for risk adjustment were collected. Risk-adjusted outcomes were compared according to whether 
the patient delivered in a hospital with condition-specific obstetric protocols at the time of 
delivery.
Results—Hemorrhage-specific protocols were not associated with a lower rate of postpartum 
hemorrhage or with fewer cases of EBL >1000cc. Similarly, in the presence of a shoulder dystocia 
protocol, there were no differences in the frequency of shoulder dystocia or number of shoulder 
dystocia maneuvers used. Conversely, preeclampsia-specific protocols were associated with fewer 
ICU admissions (OR 0.28, 95% CI 0.18–0.44) and fewer cases of severe maternal hypertension 
(OR 0.86, 95% CI 0.77–0.96).
Conclusion—The presence of condition-specific obstetric protocols was not consistently shown 
to be associated with improved risk-adjusted outcomes. Our study would suggest that the presence 
or absence of a protocol does not matter and regulations to require protocols are not fruitful.
INTRODUCTION
The importance of measuring and improving quality in obstetrics has been increasingly 
recognized as a priority. As a result, an increasing number of studies and opinions concerned 
with how to measure and improve quality of care in obstetrics have been published. 1–8 In 
this literature, the concept of using protocols to improve care has been suggested as an 
important component of patient safety initiatives. Protocols are a plan of treatment that 
provide detailed instructions for the medical team on what to do once a specific 
complication, such as hemorrhage, shoulder dystocia or preeclampsia has arisen. Pressure to 
adapt protocols may also come from government regulation and from malpractice 
carriers. 9, 10 These regulations often do not have requirements on how the protocols are 
implemented, just that a protocols are required. Correspondingly, many departments have 
started implementing condition-specific protocols.
Despite the increasing emphasis on the use of protocols to improve care, there is relatively 
little empiric evidence that obstetric outcomes are improved through their use. Also, studies 
that have demonstrated an improvement have tended to be performed at single centers, and 
as such the generalizability of the findings is uncertain. 8 One further difficulty in 
determining whether protocols are associated with better outcomes is that preexisting patient 
characteristics also influence patient outcomes, and changes over time in these 
characteristics need to be accounted for in any longitudinal study. We hypothesized that 
hospitals with condition-specific obstetric protocols in place would have better risk-adjusted 
patient outcomes than hospitals without such protocols.
Bailit et al. Page 2














Between 2008 and 2011, we performed a cohort study at 25 hospitals in the Eunice Kennedy 
Shriver National Institute of Child Health and Human Development Maternal-Fetal 
Medicine Units (MFMU) Network. This study, the Assessment of Perinatal EXcellence 
(APEX), was designed to develop quality measures for intrapartum obstetrical care. The 
APEX study was approved by the Institutional Review Board at each participating 
institution under a waiver of informed consent. This is a planned secondary analysis of the 
APEX data set.
Each hospital that participated in the study submitted all existing labor and delivery 
protocols each quarter that the study was ongoing. Research staff at participating hospitals 
was instructed to submit all potential protocols pertaining to obstetrics and to provide the 
dates that the individual protocols went into (or out of) effect. Two authors (JB and WAG) 
then independently reviewed the protocols and determined whether the submissions were 
truly condition-specific protocols (e.g., as opposed, for example, to instructions narrowly 
directed toward single medication administration) and what specific topics they pertained to 
(i.e., hemorrhage, preeclampsia, or shoulder dystocia). Protocols had to involve regulation of 
provider behavior as well as other hospital systems issues in order to be considered a 
protocol. The two reviewers determined whether a condition-specific protocol was present 
or absent for the particular center. The content and quality of the protocol as well as the 
steps taken to implement the protocol were not assessed. Disagreements were resolved by 
conversation between the two reviewers until consensus was reached.
Patients were then categorized by whether they delivered in an institution at a time when 
specific protocols were in effect. For example, if a hemorrhage and shoulder dystocia 
protocol went into effect at a given hospital in February, patients delivering in January of 
that year were categorized as not having delivered in the presence of a protocol, but patients 
from February on were categorized as having delivered in the presence of both of these 
protocols.
Methods for risk adjustment of patient characteristics, and the specific risk-adjustment 
characteristics for hemorrhage, have been described previously. 11 The same methodologies 
were used to determine the patient characteristics that should be used for risk adjustment for 
preeclampsia and shoulder dystocia. Only women eligible for a given outcome were 
included (e.g., women who did not deliver vaginally were not assessed with regard to 
shoulder dystocia). Variables used in the risk adjustment models are shown in Table 2.
Analysis was performed to determine whether risk-adjusted outcomes relevant to each 
complication were associated with the presence of relevant protocols at the time of delivery. 
For example, we assessed whether the presence of a postpartum hemorrhage protocol was 
associated with less frequent postpartum hemorrhages (i.e., estimated blood loss > 1000cc) 
or the severity of the hemorrhage (severe hemorrhage was defined as either an estimated 
blood loss ≥ 1500cc at delivery, a blood transfusion, or a hysterectomy performed for 
hemorrhage, placenta accreta or uterine atony). The analysis of the hemorrhage outcomes 
excluded women whose reason for admission was bleeding or abruption, given the greater 
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potential that their outcomes were related to events prior to admission. Only women whose 
hemorrhage started in the hospital were eligible so that hospitals were not held accountable 
for the severity of a hemorrhage when much of the blood loss was beyond their control 
before admission. For women who had been given the diagnosis of preeclampsia, we 
evaluated whether the presence of preeclampsia-specific protocols were associated with any 
of the following markers of severity: eclampsia, any persistent severe blood pressures 
defined as two maternal systolic blood pressures ≥ 160 mmHg or any two diastolic blood 
pressures ≥ 110 mmHg, admission to ICU, pulmonary edema, creatinine >2.0 mg/dl (if no 
creatinine value was present in the medical record, we assumed it did not exceed this value). 
Shoulder dystocia protocols were assessed to determine whether their presence was 
associated with the frequency of shoulder dystocia or the severity of the shoulder dystocia as 
assessed by the number of maneuvers (≤2 and ≥3) used to relieve shoulder dystocia. While 
ideally we would track poor infant outcomes for shoulder dystocia, we were unable to 
examine brachial plexus injury, cord blood gases, or bones fractures due to low numbers of 
outcomes.
Univariable comparisons were performed with Chi square tests. Hierarchal models were 
developed for the outcomes of hemorrhage and shoulder dystocia and logistic models for the 
preeclampsia outcomes, with adjustment for patient characteristics, to estimate the 
independent association between the presence of a condition-specific protocol and obstetric 
complications. Logistical models were used for the eclampsia outcomes because the low 
number of outcomes did not allow for use of a hierarchal technique. No imputation for 
missing data was performed. Hierarchal models take into account hospital of delivery and 
hospital was added to the logistics model for eclampsia.
RESULTS
Data were collected from 115,502 women. Unadjusted outcome rates are shown in Table 1. 
The frequencies of hemorrhage outcomes and ICU admission for preeclampsia were 
significantly different between hospitals with and without protocols in place. Hospitals with 
a hemorrhage protocols had higher rates of hemorrhage and hospitals that did not have a 
preeclampsia protocol in place had higher rates of ICU admissions.
Variables included in the final risk adjustment models are shown in Table 2 and the results 
of the multivariable models used to estimate the association between the presence of a 
protocol and risk-adjusted outcomes are shown in Table 3. The presence of a hemorrhage 
specific protocol was not associated with any difference in odds of hemorrhage (EBL 
>1000cc) occurring or the severity of the post partum hemorrhage in the risk adjusted 
model. Similarly, there were no differences in the odds of a shoulder dystocia occurring or 
the severity of the shoulder dystocia as in hospitals with shoulder dystocia protocols. 
Conversely, preeclampsia-specific protocols were associated with improved maternal 
outcomes as measured by lower rates of ICU admission or persistent severe maternal 
hypertension. Preeclampsia protocols were not, however, associated with other markers of 
severity such as eclampsia, pulmonary edema, or creatinine ≥2.0 mg/dl.
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In these analyses, we did not find a consistent relationship between the presence of 
condition-specific protocols and the severity of obstetrics complications. The presence of 
hemorrhage or shoulder dystocia protocols did not appear to affect the frequency of the 
outcome itself or the severity of related adverse outcomes. Conversely, the presence of a 
preeclampsia protocol was associated with less hypertensive morbidity by some measures.
It is important to recognize the importance of risk adjusting for patient factors in this 
analysis. For example, when unadjusted rates of hemorrhage are compared between 
hospitals with and without hemorrhage protocols, there appears to be a significant difference 
(Table 2). However, when patient risk factors are taken into account, these differences are 
no longer present.
We did find that preeclampsia protocols were associated with lower rates of persistent 
severe maternal hypertension and ICU admissions, but not other adverse outcomes related to 
preeclampsia. It is possible that eclampsia, pulmonary edema, and an elevated creatinine are 
sufficiently rare (with correspondingly wide confidence intervals) that this study does not 
have adequate power to detect differences in these outcomes and meaningful conclusions 
cannot be reached. The same possibility exists for adverse outcomes associated with 
shoulder dystocia.
One explanation for the finding that preeclampsia protocols changed some outcomes but that 
shoulder dystocia and hemorrhage protocols did not is that preeclampsia occurs more 
frequently in hospitals and thus providers may have better familiarity and adherence to the 
protocol. We do not have any information within this data set to be able to explore this 
hypothesis more fully.
The findings of this analysis stand in contrast to results of some prior studies. For example, 
Grobman et al. did show an improvement in outcomes after the introduction of a shoulder 
dystocia protocol at their institution.8 However, introduction of the protocol incorporated 
team simulation. Data from Pogorzelska et al. also suggest that the mere presence of a 
protocol, without other supporting systems in place, does not inevitably lead to improved 
outcomes. They surveyed ICUs to see whether they had implemented a policy to prevent 
ventilator-associated pneumonia, whether they monitored the adherence to this policy, and 
the adherence rate.. They found that a policy that was not actively monitored and that did 
not have compliance rates of 95% or greater, did not result in any effect on outcomes.12 
Similarly, Urbach et al. found that the implementation of surgical check lists in Ontario 
Hospitals did not improve patient outcomes. They speculated that while intensive team 
training or monitoring of compliance could have potentially made the checklists more 
effective, as implemented, no improvement in outcomes was seen. 13
Further evidence that it is not the protocol itself that makes a difference but that it is the 
protocol in combination with the method of implementation is found in a study by Clark et 
al.3 Researching how to decrease the rate of non-medically indicated scheduled deliveries 
<39 weeks, they studied the frequency of adherence to a new policy against such deliveries 
after three different implementation approaches: (1) education alone with no active 
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surveillance; (2) no barrier to scheduling non-medically indicated deliveries but peer review 
after one had occurred; or (3) the presence of a “hard stop” that prevented practitioners from 
scheduling a delivery that did not meet the policy. Despite a new protocol being present in 
all scenarios, a “hard stop” resulted in a significantly larger reduction in non-medically 
indicated deliveries.
In our study, we simply assessed whether a protocol was present or not present and showed 
that the presence of a protocol had little association with the presence or severity of poor 
outcomes. We were not able to assess the quality of the protocol nor quantify or categorize 
the different implementation approaches. Thus, we cannot comment whether particular 
protocols or implementation methods were associated with improved outcomes. In an effort 
to regulate and improve quality, some insurance companies request that hospitals have a 
protocol in place. Our study would suggest that the presence or absence of a protocol does 
not matter and regulation attempts along this line are not fruitful. Further research seeking to 
understand the elements of a high quality protocol or the best implementation techniques to 
use are necessary to ensure that the presence of protocols translates into improved outcomes. 
Merely requiring that a hospital have a protocol is not enough to affect outcomes.
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Table 1
Unadjusted outcomes by protocol status
Descriptive table of outcomes by protocol status
Hospital did not have a 
hemorrhage protocol at time of 
delivery (N=85,291)
Hospital did have a hemorrhage 




EBL>1000 cc 7,381 (8.7%) 4,240 (16.2%) <0.01
Severe PPH 1,772 (2.1%) 679 (2.6%) <0.01
Hospital did not have a dystocia 
protocol at time of delivery 
(N=59,852)
Hospital did have a dystocia 
protocol at time of delivery 
(N=18,503)
P-value comparing these 
groups
Shoulder dystocia 1,641 (2.7%) 469 (2.5%) 0.13
Number of maneuvers ≥3 285 (0.5%) 117 (0.6%) 0.02
Hospital did not have a preeclampsia 
protocol at time of delivery 
(N=9,598)
Hospital did have a preeclampsia 
protocol at time of delivery 
(N=1,931)
P-value comparing these 
groups
Eclampsia 32 (0.3%) 10 (0.5%) 0.22
Severe Hypertension* 4,345 (45%) 800 (41%) 0.002
Admission to ICU 373 (3.9%) 22 (1.1%) <0.0001
Pulmonary edema 104 (1.1%) 19 (0.98%) 0.81
Creatinine ≥2 mg/dL (if missing 
assume < 2)
80 (0.83%) 18 (0.93%) 0.69
*
Any two maternal SBP ≥ 160 mmHg or any two maternal DBP ≥ 110 mmHg
N = number of women delivering in hospitals during period with or without a specific protocol
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Table 2
Patient risk adjustors by condition type
Postpartum Hemorrhage Shoulder dystocia Preeclampsia
Denominator size for each outcome (with all non-missing covariates) 105,165 75,910 11,529
Maternal characteristics
Age ● ●
Body mass index at delivery ● ●
Cigarette use during pregnancy
Cocaine or methamphetamine use during pregnancy
Insurance status ● ● ●
More than two prenatal care visits ●
Obstetric history ● ●
Any hypertension ●
Diabetes mellitus ● ●







Type of Labor ●
Gestational Age ● ●
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Table 3
Risk-Adjusted outcomes by protocol status
Outcome Odds ratios associated with having a protocol 
for the specified complication
Lower CI Upper CI P
 Hemorrhage outcomes
Post partum hemorrhage 0.96 0.83 1.11 0.52
EBL >1000cc 0.94 0.87 1.02 0.14
Shoulder dystocia outcomes
Shoulder dystocia 1.01 0.86 1.19 0.93
Number of maneuvers ≥3 1.23 0.84 1.81 0.27
Preeclampsia/gestational HTN outcomes
Eclampsia 1.54 0.74 3.21 0.25
Severe hypertension* 0.86 0.77 0.96 < 0.01
ICU admission 0.28 0.18 0.44 < 0.01
Pulmonary edema 0.95 0.57 1.58 0.84
Creatinine ≥ 2 mg/dL 1.18 0.71 1.97 0.53
*
Any two maternal SBP ≥ 160 mmHg or any two maternal DBP ≥ 110 mmHg
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